HomeIVBXF • OTCMKTS
add
Innovent Biologics Inc
Previous close
$4.85
Year range
$3.83 - $6.40
Market cap
61.86B HKD
Avg Volume
794.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.98B | 46.30% |
Operating expense | 1.65B | 24.69% |
Net income | -196.31M | -182.16% |
Net profit margin | -9.93 | -92.82% |
Earnings per share | — | — |
EBITDA | -124.43M | 54.47% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.63B | 1.20% |
Total assets | 20.30B | 13.40% |
Total liabilities | 7.87B | 10.62% |
Total equity | 12.43B | — |
Shares outstanding | 1.63B | — |
Price to book | 0.64 | — |
Return on assets | -2.66% | — |
Return on capital | -3.43% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -196.31M | -182.16% |
Cash from operations | -107.82M | 65.38% |
Cash from investing | -276.84M | -176.37% |
Cash from financing | -130.41M | -206.59% |
Net change in cash | -515.87M | -426.40% |
Free cash flow | -283.39M | 18.15% |
About
CEO
Founded
Apr 28, 2011
Website
Employees
5,263
